125 related articles for article (PubMed ID: 19621336)
1. c-Rel is a transcriptional repressor of EPHB2 in colorectal cancer.
Fu T; Li P; Wang H; He Y; Luo D; Zhang A; Tong W; Zhang L; Liu B; Hu C
J Pathol; 2009 Sep; 219(1):103-13. PubMed ID: 19621336
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of inactivation of the receptor tyrosine kinase EPHB2 in colorectal tumors.
Alazzouzi H; Davalos V; Kokko A; Domingo E; Woerner SM; Wilson AJ; Konrad L; Laiho P; Espín E; Armengol M; Imai K; Yamamoto H; Mariadason JM; Gebert JF; Aaltonen LA; Schwartz S; Arango D
Cancer Res; 2005 Nov; 65(22):10170-3. PubMed ID: 16288001
[TBL] [Abstract][Full Text] [Related]
3. Reduced expression of EphB2 that parallels invasion and metastasis in colorectal tumours.
Guo DL; Zhang J; Yuen ST; Tsui WY; Chan AS; Ho C; Ji J; Leung SY; Chen X
Carcinogenesis; 2006 Mar; 27(3):454-64. PubMed ID: 16272170
[TBL] [Abstract][Full Text] [Related]
4. EphB2 is a prognostic factor in colorectal cancer.
Jubb AM; Zhong F; Bheddah S; Grabsch HI; Frantz GD; Mueller W; Kavi V; Quirke P; Polakis P; Koeppen H
Clin Cancer Res; 2005 Jul; 11(14):5181-7. PubMed ID: 16033834
[TBL] [Abstract][Full Text] [Related]
5. EPHB2 germline variants in patients with colorectal cancer or hyperplastic polyposis.
Kokko A; Laiho P; Lehtonen R; Korja S; Carvajal-Carmona LG; Järvinen H; Mecklin JP; Eng C; Schleutker J; Tomlinson IP; Vahteristo P; Aaltonen LA
BMC Cancer; 2006 Jun; 6():145. PubMed ID: 16740153
[TBL] [Abstract][Full Text] [Related]
6. Preferential induction of EphB4 over EphB2 and its implication in colorectal cancer progression.
Kumar SR; Scehnet JS; Ley EJ; Singh J; Krasnoperov V; Liu R; Manchanda PK; Ladner RD; Hawes D; Weaver FA; Beart RW; Singh G; Nguyen C; Kahn M; Gill PS
Cancer Res; 2009 May; 69(9):3736-45. PubMed ID: 19366806
[TBL] [Abstract][Full Text] [Related]
7. EphB2 expression across 138 human tumor types in a tissue microarray: high levels of expression in gastrointestinal cancers.
Lugli A; Spichtin H; Maurer R; Mirlacher M; Kiefer J; Huusko P; Azorsa D; Terracciano L; Sauter G; Kallioniemi OP; Mousses S; Tornillo L
Clin Cancer Res; 2005 Sep; 11(18):6450-8. PubMed ID: 16166419
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of EphA4 gene and reduced expression of EphB2 gene correlates with liver metastasis in colorectal cancer.
Oshima T; Akaike M; Yoshihara K; Shiozawa M; Yamamoto N; Sato T; Akihito N; Nagano Y; Fujii S; Kunisaki C; Wada N; Rino Y; Tanaka K; Masuda M; Imada T
Int J Oncol; 2008 Sep; 33(3):573-7. PubMed ID: 18695888
[TBL] [Abstract][Full Text] [Related]
9. Genetic and epigenetic analysis of the EPHB2 gene in gastric cancers.
Song JH; Kim CJ; Cho YG; Kwak HJ; Nam SW; Yoo NJ; Lee JY; Park WS
APMIS; 2007 Feb; 115(2):164-8. PubMed ID: 17295683
[TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase-2 inhibitors down-regulate osteopontin and Nr4A2-new therapeutic targets for colorectal cancers.
Zagani R; Hamzaoui N; Cacheux W; de Reyniès A; Terris B; Chaussade S; Romagnolo B; Perret C; Lamarque D
Gastroenterology; 2009 Oct; 137(4):1358-66.e1-3. PubMed ID: 19549529
[TBL] [Abstract][Full Text] [Related]
11. Influence of A9 region mutation in EphB2 gene in the prognosis of patients with colorectal adenocarcinoma.
Vidaurreta M; Rafael S; Veganzones S; de la Orden V; Fernández C; Gómez-Casaseca R; Cerdán J; Maestro M
Ann Surg Oncol; 2011 May; 18(5):1501-5. PubMed ID: 21161727
[TBL] [Abstract][Full Text] [Related]
12. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
[TBL] [Abstract][Full Text] [Related]
13. EphB receptor activity suppresses colorectal cancer progression.
Batlle E; Bacani J; Begthel H; Jonkheer S; Gregorieff A; van de Born M; Malats N; Sancho E; Boon E; Pawson T; Gallinger S; Pals S; Clevers H
Nature; 2005 Jun; 435(7045):1126-30. PubMed ID: 15973414
[TBL] [Abstract][Full Text] [Related]
14. A negative feedback regulatory loop associates the tyrosine kinase receptor ERBB2 and the transcription factor GATA4 in breast cancer cells.
Hua G; Zhu B; Rosa F; Deblon N; Adélaïde J; Kahn-Perlès B; Birnbaum D; Imbert J
Mol Cancer Res; 2009 Mar; 7(3):402-14. PubMed ID: 19276186
[TBL] [Abstract][Full Text] [Related]
15. Characterization of promoter regulatory elements involved in downexpression of the DNA polymerase kappa in colorectal cancer.
Lemée F; Bavoux C; Pillaire MJ; Bieth A; Machado CR; Pena SD; Guimbaud R; Selves J; Hoffmann JS; Cazaux C
Oncogene; 2007 May; 26(23):3387-94. PubMed ID: 17099721
[TBL] [Abstract][Full Text] [Related]
16. Cupredoxin-cancer interrelationship: azurin binding with EphB2, interference in EphB2 tyrosine phosphorylation, and inhibition of cancer growth.
Chaudhari A; Mahfouz M; Fialho AM; Yamada T; Granja AT; Zhu Y; Hashimoto W; Schlarb-Ridley B; Cho W; Das Gupta TK; Chakrabarty AM
Biochemistry; 2007 Feb; 46(7):1799-810. PubMed ID: 17249693
[TBL] [Abstract][Full Text] [Related]
17. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ
Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681
[TBL] [Abstract][Full Text] [Related]
18. Expression and function of ephrin-B1 and its cognate receptor EphB2 in human atherosclerosis: from an aspect of chemotaxis.
Sakamoto A; Ishibashi-Ueda H; Sugamoto Y; Higashikata T; Miyamoto S; Kawashiri MA; Yagi K; Konno T; Hayashi K; Fujino N; Ino H; Takeda Y; Yamagishi M
Clin Sci (Lond); 2008 May; 114(10):643-50. PubMed ID: 18092944
[TBL] [Abstract][Full Text] [Related]
19. High EPHB2 mutation rate in gastric but not endometrial tumors with microsatellite instability.
Davalos V; Dopeso H; Velho S; Ferreira AM; Cirnes L; Díaz-Chico N; Bilbao C; Ramírez R; Rodríguez G; Falcón O; León L; Niessen RC; Keller G; Dallenbach-Hellweg G; Espín E; Armengol M; Plaja A; Perucho M; Imai K; Yamamoto H; Gebert JF; Díaz-Chico JC; Hofstra RM; Woerner SM; Seruca R; Schwartz S; Arango D
Oncogene; 2007 Jan; 26(2):308-11. PubMed ID: 16819508
[TBL] [Abstract][Full Text] [Related]
20. Involvement of Vitamin D receptor in the intestinal induction of human ABCB1.
Tachibana S; Yoshinari K; Chikada T; Toriyabe T; Nagata K; Yamazoe Y
Drug Metab Dispos; 2009 Aug; 37(8):1604-10. PubMed ID: 19460946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
